Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Immunisation”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Not applicableStudy completedNCT03614676
What this trial is testing

Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 4,493
Large-scale testing (Phase 3)Study completedNCT05437510
What this trial is testing

Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life

Who this might be right for
RSV ImmunizationHealthy Volunteer
Sanofi Pasteur, a Sanofi Company 8,057
Early research (Phase 1)Study completedNCT04354480
What this trial is testing

Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 36
Large-scale testing (Phase 3)Looking for participantsNCT07232706
What this trial is testing

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Who this might be right for
RSV Immunization
Centre Hospitalier Annecy Genevois 1,000
Not applicableActive Not RecruitingNCT07251972
What this trial is testing

Comparison of Two Methods of Immunoprophylaxis Against RSV in Term Newborns

Who this might be right for
Bronchiolitis
Jean-Michel HASCOET 1,050
Not applicableNot Yet RecruitingNCT07235397
What this trial is testing

Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 1
Not applicableStudy completedNCT07164430
What this trial is testing

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Nicola Irwin 2,792
Post-approval studies (Phase 4)Active Not RecruitingNCT07109297
What this trial is testing

Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India

Who this might be right for
RSV Immunization
Sanofi 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654
What this trial is testing

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Who this might be right for
Human Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 1,530
Post-approval studies (Phase 4)Not Yet RecruitingNCT07693166
What this trial is testing

Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF

Who this might be right for
RSV ImmunizationHIV
University of British Columbia 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07041190
What this trial is testing

Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.

Who this might be right for
RSV Immunization
PENTA Foundation 1,500
Not applicableStudy completedNCT02282982
What this trial is testing

Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis

Who this might be right for
Respiratory Syncytial Virus (RSV)
AbbVie 359
Not applicableNot Yet RecruitingNCT07445763
What this trial is testing

TARSILA Real-World Evidence Study

Who this might be right for
Respiratory Syncytial Virus (RSV)Maternal ImmunizationAcute Respiratory Illness (ARI)+2 more
Inova Medical 5,000
Not applicableActive Not RecruitingNCT06993753
What this trial is testing

Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Viral (RSV) Infections
Griffith University 4,350
Not applicableUnknownNCT06259487
What this trial is testing

Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.

Who this might be right for
Heart FailureRSV InfectionInfluenza+1 more
Wroclaw Medical University 250
Early research (Phase 1)Study completedNCT06850051
What this trial is testing

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Who this might be right for
Healthy VolunteersInfluenza VaccinationRespiratory Syncytial Virus Vaccination+2 more
Sanofi 270
Not applicableActive Not RecruitingNCT06647654
What this trial is testing

Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy

Who this might be right for
Respiratory Syncytial VirusRespiratory Tract Diseases
Pfizer 1
Large-scale testing (Phase 3)Ended earlyNCT06397768
What this trial is testing

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunization
Sanofi Pasteur, a Sanofi Company 2,226
Large-scale testing (Phase 3)WithdrawnNCT05229068
What this trial is testing

Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline
Not applicableLooking for participantsNCT06881953
What this trial is testing

Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France

Who this might be right for
RSV Infection
Assistance Publique - Hôpitaux de Paris 400
Next Page